Author's reply: Nucleo(s)tide analogue withdrawal in chronic hepatitis B virus infection. Beyond the HBsAg loss. Issue 9 (September 2022)

Record Type:: Journal Article
Title:: Author's reply: Nucleo(s)tide analogue withdrawal in chronic hepatitis B virus infection. Beyond the HBsAg loss. Issue 9 (September 2022)
Main Title:: Author's reply: Nucleo(s)tide analogue withdrawal in chronic hepatitis B virus infection. Beyond the HBsAg loss
Authors:: Broquetas, Teresa
Carrión, Jose A.
Abstract:
Is Part Of:: Digestive and liver disease. Volume 54:Issue 9(2022)
Journal:: Digestive and liver disease
Issue:: Volume 54:Issue 9(2022)
Issue Display:: Volume 54, Issue 9 (2022)
Year:: 2022
Volume:: 54
Issue:: 9
Issue Sort Value:: 2022-0054-0009-0000
Page Start:: 1283
Page End:: 1284
Publication Date:: 2022-09
Subjects:: Antiviral -- Efficacy -- Hepatocellular -- Stop
HCC hepatocellular carcinoma -- CHB chronic hepatitis B -- HBsAg hepatitis B surface antigen -- HBV hepatitis B virus -- NA nucleo(s)tide analogues -- ETV entecavir -- TDF tenofovir
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005
Journal URLs:: http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.dld.2022.04.020 ↗
Languages:: English
ISSNs:: 1590-8658
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 23060.xml